MGNX
MacroGenics Inc
NASDAQ: MGNX · HEALTHCARE · BIOTECHNOLOGY
$3.08
+4.76% today
Updated 2026-04-30
Market cap
$193.86M
P/E ratio
—
P/S ratio
1.30x
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$1 – $4
Volume
1.1M
MacroGenics Inc (MGNX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6.76M | $-6.58M | $-14.17M | $-32.76M | $-13.66M | $-43.68M | $14.40M | $-153.23M | $-134.27M | $-111.90M | $-143.83M | $-86.96M | $-78.20M | $-68.37M | $-81.04M |
| Capital expenditures | $500213.00 | $940043.00 | $2.96M | $3.57M | $9.20M | $11.38M | $29.40M | $24.95M | $4.29M | $5.91M | $6.20M | $3.62M | $1.76M | $3.71M | $1.91M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.35M | $838395.00 | $862162.00 | $3.24M | $7.85M | $12.16M | $14.74M | $16.52M | $19.57M | $20.68M | $23.13M | $20.44M | $18.37M | $29.44M | $14.29M |
| Free cash flow | $6.26M | $-7.52M | $-17.13M | $-36.33M | $-22.86M | $-55.06M | $-15.00M | $-178.19M | $-138.56M | $-117.80M | $-150.03M | $-90.58M | $-79.97M | $-72.08M | $-82.95M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $68.74M | $41.11M | $38.58M | $-112.07M | $127.63M | $8.40M | — | $54.66M | $-57.66M | $-14.59M | — | — | — |